Skip to content

Insider · CIK 0001937048

Scott T Reents

cfoofficer

Files at ABBV (AbbVie Inc.). First filing Mar 18, 2025, latest Mar 18, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $3.7M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ABBV: AbbVie Inc.

ABBVOct 9, 2026 · close 276.47

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
82Strong
ABBVsell 4
AbbVie Inc.
$3.7M
17,644 shares
-60%+30% from low-2% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 14, 2025ABBV
AbbVie Inc.
SOpen-market sale
Common Stock, $0.01 par value
-17,644$212.34$3.7M11,577Mar 18, 2025
Feb 28, 2025ABBV
AbbVie Inc.
FTax withholding
Common Stock, $0.01 par value
-10,973$205.02$2.2M29,221Mar 4, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+5,845$0.00$021,276Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+2,398$0.00$023,674Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+8,912$0.00$032,586Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Common Stock, $0.01 par value
+7,608$0.00$040,194Feb 18, 2025
Feb 13, 2025ABBV
AbbVie Inc.
AGrant or award
Option (Right to buy)derivative
+27,343$0.00$027,343Feb 18, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Scott T Reents: insider trades and track record | InsiderTell